No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 30 | 69 | 88 | 73 | 76 | 48 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | -36 | -14 | -0 | -10 | -5 | -14 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Singulus Technologies AG is a global enterprise that specializes in the design, construction, and sale of advanced manufacturing equipment. Its core expertise spans vacuum deposition, surface engineering, wet chemical, and thermal processing technologies. The company strategically organizes its operations into three main business segments: Solar, Life Science, and Semiconductor. The Solar division is dedicated to developing production solutions for various solar cell designs. This includes cutting-edge concepts like heterojunction, interdigitated back contact (IBC), and tunnel oxide passivated contacts (TOPCon), applicable to both crystalline and thin-film solar cells. Within the Life Science segment, Singulus Technologies offers specialized product solutions for medical technology, decorative coatings, and data storage. Key offerings in this area include the integrated DECOLINE II product line, the POLYCOATER inline vacuum cathode sputtering machine, and the MEDLINE series, specifically tailored for medical applications. Additionally, this segment supplies machinery for the production of optical data carriers, such as CDs, DVDs, dual-layer Blu-ray, and Ultra HD Blu-ray discs. The Semiconductor segment provides custom-engineered machines and sophisticated platforms, notably TIMARIS and ROTARIS. These are deployed in the manufacturing of components like magnetoresistive random-access memory (MRAM), sensors, power controllers, and microelectromechanical systems (MEMS). Founded in 1995, Singulus Technologies AG is headquartered in Kahl am Main, Germany.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Singulus Technologies AG (SNG.DE)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Singulus Technologies AG is a global enterprise that specializes in the design, construction, and sale of advanced manufacturing equipment. Its core expertise spans vacuum deposition, surface engineering, wet chemical, and thermal processing technologies. The company strategically organizes its operations into three main business segments: Solar, Life Science, and Semiconductor. The Solar division is dedicated to developing production solutions for various solar cell designs. This includes cutting-edge concepts like heterojunction, interdigitated back contact (IBC), and tunnel oxide passivated contacts (TOPCon), applicable to both crystalline and thin-film solar cells. Within the Life Science segment, Singulus Technologies offers specialized product solutions for medical technology, decorative coatings, and data storage. Key offerings in this area include the integrated DECOLINE II product line, the POLYCOATER inline vacuum cathode sputtering machine, and the MEDLINE series, specifically tailored for medical applications. Additionally, this segment supplies machinery for the production of optical data carriers, such as CDs, DVDs, dual-layer Blu-ray, and Ultra HD Blu-ray discs. The Semiconductor segment provides custom-engineered machines and sophisticated platforms, notably TIMARIS and ROTARIS. These are deployed in the manufacturing of components like magnetoresistive random-access memory (MRAM), sensors, power controllers, and microelectromechanical systems (MEMS). Founded in 1995, Singulus Technologies AG is headquartered in Kahl am Main, Germany.